Related Experiment Video
Updated: May 28, 2026

Bacteriophage Removal from Infected Salmonella Cultures
Published on: June 28, 2024
PEGylating a bacteriophage endolysin inhibits its bactericidal activity
Gregory Resch1, Philippe Moreillon, Vincent A Fischetti
1Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA. gregory.resch@unil.ch.
PEGylation, a method to extend protein half-life, failed to enhance the activity of bacteriophage endolysins (lysins) against Streptococcus pneumoniae. The PEGylation process inhibited the enzybiotic
Area of Science:
- Microbiology
- Biochemistry
- Drug Development
Background:
- Bacteriophage endolysins (lysins) are enzymes that degrade bacterial peptidoglycan, causing cell lysis.
- Lysins show therapeutic potential as enzybiotics against Gram-positive bacteria, including Streptococcus pneumoniae.
- Systemic administration of proteins like lysins results in rapid clearance from circulation, limiting their therapeutic efficacy.
Purpose of the Study:
- To investigate the efficacy of PEGylation in extending the in vivo half-life and maintaining the lytic activity of the bacteriophage lysin Cpl-1.
- To evaluate the impact of cysteine-specific PEGylation on the antimicrobial properties of Cpl-1 against Streptococcus pneumoniae.
Main Methods:
- Cpl-1 lysin mutants with an additional cysteine residue were generated for site-specific PEGylation.
- Cysteine-specific PEGylation was performed using polyethylene glycol (PEG) molecules of 10K and 40K molecular weights.
- In vitro lytic activity of native Cpl-1, mutant Cpl-1, and PEGylated Cpl-1 conjugates against Streptococcus pneumoniae was assessed.
Main Results:
- Successful cysteine-specific PEGylation of Cpl-1 mutants with PEG 10K and 40K was achieved.
- None of the PEGylated Cpl-1 conjugates retained significant in vitro lytic activity against Streptococcus pneumoniae.
- The introduction of the cysteine residue alone did not affect the antimicrobial activity of the mutant enzymes.
Conclusions:
- PEGylation, via a cysteine-specific strategy, inhibits the antimicrobial activity of bacteriophage lysin Cpl-1.
- This study suggests that cysteine-specific PEGylation is not a viable strategy for improving the in vivo half-life of bacteriophage endolysins as enzybiotics.
- The modular structure of most endolysins may present inherent challenges for PEGylation strategies aimed at enhancing their therapeutic potential.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Inhibitors of Gram-positive Cell Wall Synthesis
Viral Replication: Lysogenic Cycle
DNA Bacteriophages

